Paradigm Biopharmaceuticals Limited Stock
Stocks
PAR
AU000000PAR5
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
10:10:27 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.2650 AUD | +10.42% |
|
+26.19% | -22.06% |
| Market Cap | 159M 114M 98.49M 92.67M 84.65M 158M 10.81B 1.09B 425M 5.54B 430M 420M 17.86B | P/E 2027 * |
-3.19x | P/E 2028 * | 1.46x |
|---|---|---|---|---|---|
| Enterprise Value | 147M 106M 91.05M 85.66M 78.25M 146M 9.99B 1.01B 393M 5.13B 397M 389M 16.51B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | -0.31x |
| Free-Float |
91.43% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PAR | Delayed | |
OTC Markets
| PBIGF | Delayed | |
|
Deutsche Boerse AG
| P86 | Delayed | |
|
Börse Stuttgart
| P86 | Delayed | |
|
Tradegate
| P86 | Real-time | |
|
Boerse Muenchen
| P86 | Real-time |
| 1 day | +10.42% | ||
| 1 week | +26.19% | ||
| Current month | +17.78% | ||
| 1 month | +47.22% | ||
| 3 months | +82.76% | ||
| 6 months | +3.92% | ||
| Current year | -22.06% |
| 1 week | 0.2 |  | 0.28 |
| 1 month | 0.17 | | 0.28 |
| Current year | 0.14 | | 0.37 |
| 1 year | 0.14 | | 0.47 |
| 3 years | 0.14 | | 0.78 |
| 5 years | 0.14 | | 2.69 |
| 10 years | 0.14 | | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Rennie
CEO | Chief Executive Officer | - | 22/11/2022 |
| Director of Finance/CFO | - | 03/03/2023 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Rennie
CHM | Chairman | - | - |
Amos Meltzer
BRD | Director/Board Member | 60 | 09/12/2020 |
Matthew Fry
BRD | Director/Board Member | - | 04/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/06/26 | Buy | Chief Executive Officer | 176,470 | 0.0336% | ||
| 02/06/26 | Buy | Chief Executive Officer | 176,470 | 0.0336% | ||
| 02/06/26 | Buy | Chief Executive Officer | 176,470 | 0.0336% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.42% | +26.19% | -5.36% | -60.74% | 114M | |
| -2.54% | -2.84% | -1.77% | +14.72% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +523.39% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +21.22% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +74.90% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +47.12% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +123.04% | 16.5B | |
| -1.01% | +0.50% | +13.91% | +31.45% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.22% | 13.77B | |
| Average | +0.22% | +3.10% | +65.23% | +90.70% | 27.51B | |
| Weighted average by Cap. | -1.03% | +0.12% | +89.38% | +127.85% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 322M 232M 200M 188M 172M 321M 21.91B 2.22B 861M 11.24B 871M 852M 36.21B |
| Net income | -44.8M -32.29M -27.79M -26.14M -23.88M -44.68M -3.05B -309M -120M -1.56B -121M -119M -5.04B | 99.5M 71.72M 61.72M 58.07M 53.04M 99.23M 6.77B 686M 266M 3.47B 269M 263M 11.19B |
| Net Debt | -12M -8.65M -7.44M -7M -6.4M -11.97M -817M -82.75M -32.11M -419M -32.48M -31.77M -1.35B | -260M -187M -161M -152M -139M -259M -17.69B -1.79B -696M -9.08B -704M -688M -29.25B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | A$0.2650 | +10.42% | 6,334,002 |
| 03/09/26 | A$0.2400 | +9.09% | 3,213,003 |
| 02/09/26 | A$0.2200 | +7.32% | 2,122,949 |
| 01/09/26 | A$0.2050 | -8.89% | 2,753,722 |
| 31/08/26 | A$0.2250 | +7.14% | 4,031,040 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PAR Stock
Select your edition
All financial news and data tailored to specific country editions
